Medicare Enrolled
Dr. Charles Spielman, MD
Cardiovascular Disease · Cape May Court House, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Spielman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Spielman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Spielman
Dr. Charles Spielman is a cardiovascular disease specialist in Cape May Court House, NJ, with 17 years of NPI registration. Based on federal Medicare data, Dr. Spielman performed 1,318 Medicare services across 728 unique beneficiaries.
Between the years covered by Open Payments, Dr. Spielman received a total of $9,649 from 47 pharmaceutical and/or device companies across 337 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Spielman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ 1,318 Medicare services
$9,649 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,318
Medicare services
Bottom 21% in NJ for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
728
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~78 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
335 | $92 | $248 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
312 | $66 | $395 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
112 | $57 | $385 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
76 | $45 | $58 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
73 | $108 | $300 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
73 | $111 | $216 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
60 | $12 | $87 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
57 | $99 | $495 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
32 | $63 | $1,313 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
26 | $111 | $220 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
23 | $132 | $270 |
| Annual depression screening | 23 | $20 | $31 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
22 | $12 | $27 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $121 | $377 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
19 | $33 | $152 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $33 | $50 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
15 | $72 | $100 |
| Right heart catheterization A procedure where a thin, flexible tube is inserted into the right side of the heart to measure pressure and oxygen levels. |
12 | $107 | $978 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
11 | $55 | $243 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.4% high complexity
14.1% medium
76.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,649
Total received (2018-2024)
Avg $1,378/year across 7 years
Top 21% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
337
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,649 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$952
2023
$1,737
2022
$1,100
2021
$1,686
2020
$1,009
2019
$1,962
2018
$1,202
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$226
AstraZeneca Pharmaceuticals LP
$179
UCB, Inc.
$125
Teva Pharmaceuticals USA, Inc.
$123
Neurocrine Biosciences, Inc.
$123
Novo Nordisk Inc
$48
Novartis Pharmaceuticals Corporation
$38
Janssen Pharmaceuticals, Inc
$32
Merck Sharp & Dohme LLC
$31
WATERMARK MEDICAL, INC.
$17
CVRx, Inc.
$11
Top 3 companies account for 55.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$1,211
Novo Nordisk Inc
$950
AstraZeneca Pharmaceuticals LP
$702
Teva Pharmaceuticals USA, Inc.
$565
Boehringer Ingelheim Pharmaceuticals, Inc.
$564
Impulse Dynamics (USA) Inc.
$458
Kowa Pharmaceuticals America, Inc.
$419
Amgen Inc.
$385
ARBOR PHARMACEUTICALS, INC.
$372
Novartis Pharmaceuticals Corporation
$287
Boston Scientific Corporation
$275
Abbott Laboratories
$255
ACADIA Pharmaceuticals Inc
$245
Cardiovascular Systems Inc.
$204
Amarin Pharma Inc.
$199
Merck Sharp & Dohme LLC
$180
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$152
Lilly USA, LLC
$133
Inari Medical, Inc.
$132
IMPULSE DYNAMICS (USA) INC.
$125
Esperion Therapeutics, Inc.
$125
UCB, Inc.
$125
Sumitomo Pharma America, Inc.
$124
Neurocrine Biosciences, Inc.
$123
Celgene Corporation
$122
SK Life Science, Inc.
$118
Sunovion Pharmaceuticals Inc.
$117
Bayer HealthCare Pharmaceuticals Inc.
$114
GlaxoSmithKline, LLC.
$111
Nestle HealthCare Nutrition Inc.
$110
E.R. Squibb & Sons, L.L.C.
$96
Lundbeck LLC
$79
Stryker Corporation
$74
Merck Sharp & Dohme Corporation
$67
Azurity Pharmaceuticals, Inc.
$48
Biosense Webster, Inc.
$41
PFIZER INC.
$37
Regeneron Healthcare Solutions, Inc.
$34
Gilead Sciences, Inc.
$34
Akcea Therapeutics, Inc.
$31
Lexicon Pharmaceuticals, Inc.
$24
WATERMARK MEDICAL, INC.
$17
SANOFI-AVENTIS U.S. LLC
$14
AngioDynamics, Inc.
$14
Bayer Healthcare Pharmaceuticals Inc.
$14
Medtronic MiniMed, Inc.
$12
CVRx, Inc.
$11
Top 3 companies account for 29.7% of all-time payments
Associated products mentioned in payments ›
AJOVY · ARES 620 UNICORDER · AUSTEDO · Adempas · Allure CRT Pacemaker · Austedo XR · BREZTRI · BRILINTA · Barostim Neo System · Bidil · CAMZYOS · CHANTIX · Carto 3 System · Corlanor · EDARBI · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Ensite Cardiac Mapping System · FARXIGA · FLOWTRIEVER CATHETER · GEMTESA · Guardian Connect · HeartMate 3 Left Ventricular Dev · INGREZZA · Inpefa · JANUVIA · JARDIANCE · LEQVIO · LOKELMA · LONHALA MAGNAIR · LifeVest · Livalo · NEXLIZET · NORTHERA · NUPLAZID · Nayzilam · OPTIMIZER · OPTIMIZER SMART SYSTEM · Optimizer · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · RYBELSUS · Ranexa · Repatha · Rybelsus · S · SOLIQUA · STEGLATRO · Seglentis · TEGSEDI · TRELEGY ELLIPTA · TREVO · TRULICITY · Tresiba · VERQUVO · VYNDAQEL · Vascepa · Verquvo · Victoza · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · XCOPRI · Xultophy 100/3.6 · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
23
Per 100K population
24.2
County median income
$88,046
Nearest hospital
CAPE REGIONAL MEDICAL CENTER INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Spielman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Spielman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Spielman performed 335 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Spielman receive payments from pharmaceutical companies?
Yes. Dr. Spielman received a total of $9,649 from 47 companies across 337 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Spielman's costs compare to other cardiologists in Cape May Court House?
Dr. Spielman's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Spielman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Cape May Court House
Browse cardiologists in Cape May Court House ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology